Skip to main content

Advertisement

Log in

Evaluation of pedometer use in men with lower urinary tract symptoms: a randomized clinical trial

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To assess the effect of a pedometer use in men aged between 50 and 59 years presenting lower urinary tract symptoms (LUTS).

Methods

A single-center, not blind clinical trial with two parallel groups and equal randomization was performed with 38 men aged 50–59 years with LUTS. All patients received guidance and encouragement to physical activity practice. Only the intervention group received a Pedometer with a goal of 10,000 steps/day. After a period of 12 weeks, the groups were compared through the following variables: number of steps/day, IPSS score, flexibility, anthropometric values and Maximum Oxygen Consumption (VO2max).

Results

The number of steps per day in the intervention group was 9753 ± 1549 compared to 6212 ± 1152 in the control group (p = 0.004). Pedometer use efficacy was a 50% risk reduction of not achieve the goal of 10,000 steps per day. Regarding IPSS score, the intervention group achieved lower scores (6.95 ± 2.85 vs. 10.16 ± 3.23, p = 0.007). Pedometer use efficacy was a 94% risk reduction of not achieve more than 30% reduction in IPSS score.

In VO2max, the intervention group performed better than the control group (34.84 ± 3.25 vs. 32.58 ± 6.89; p = 0.011). There was no difference in flexibility and anthropometric values between the groups.

Conclusions

The use of pedometer in LUTS patients provided an increase in the number of steps/day, a decrease in LUTS score and an improvement in VO2max measure.

Clinical Trial Registration

Trial url: www.ensaiosclinicos.gov.br/rg/RBR-4vynk5/. Register Number: RBR-4vynk5 .

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The data and material are available through request.

References

  1. Robertson C, Link CL, Onel E et al (2007) The impact of lower urinary tract symptoms and comorbidities on quality of life : the Bach and UREPIK studies. BJU Int 99:347–354

    Article  Google Scholar 

  2. Parsons JK, Bergstrom J, Silberstein J et al (2008) Prevalence and characteristics of lower urinary tract symptoms in men aged or 80 years. Urology 72:318–321

    Article  Google Scholar 

  3. Parsons JK (2007) Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178:395–440

    Article  Google Scholar 

  4. Parsons JK, Kashefi C (2008) Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53:1228–1235

    Article  Google Scholar 

  5. Rohrmann S, Smit E, Giovannucci E et al (2004) Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the third national health and nutrition examination survey. Am J Epidem 159:390–397

    Article  Google Scholar 

  6. Brum CS, Rezende EC, De Lima JR, Santos IC, Netto JM, Figueiredo AA (2013) Association of lower urinary tract symptoms and maximal oxygen uptake (Vo2max) in men aged 50 to 59 years: a case-control study. Urology 82(4):876–880

    Article  Google Scholar 

  7. Albright C, Thompson DL (2006) The effectiveness of walking in preventing cardiovascular disease in women; a review of the current literature. J Women’s Health 15(3):271–280

    Article  Google Scholar 

  8. Iwane M, Arita M, Tomimoto S, Satani O, Matsumoto M, Miyashita K, Nishio I (2000) Walking 10,000 steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension. Hypertens Res 23(6):573–580

    Article  CAS  Google Scholar 

  9. Tudor-Locke C, Bassett DR, Swartz AM et al (2004) A preliminary study of one year of pedometer self-monitoring. Ann Behav Med 28(3):158–162

    Article  Google Scholar 

  10. Barry MJ, Fowler FJ, Oleary MP et al (1992) The American urological association symptom index for benign prostatic hyperplasia. J Urol 148:1549–1557

    Article  CAS  Google Scholar 

  11. Clarke TC, Norris T, Schiller JS (2017) Early release of selected estimates based on data from the 2016 national health interview survey

  12. - World Health Organization (2017) Physical activity [Fact sheet]. http://www.who.int/mediacentre/factsheets/fs385/en/

  13. Tudor-Locke C, Williams JE, Reis JP, Pluto D (2002) Utility of pedometers for assessing physical activity. Sports Med 32:795–808

    Article  Google Scholar 

  14. Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA (2005) Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health ANd Nutrition Examination Survey. BJU Int 96:77–82

    Article  Google Scholar 

  15. Pashootan P, Ploussard G, Cocaul A, de Gouvello A, Desgrandchamps F (2015) Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort. BJU Int 116:124–130

    Article  Google Scholar 

  16. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177:1395–1400

    Article  Google Scholar 

  17. Rohrmann S, Smit E, Giovannucci E et al (2004) Association of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 159:390

    Article  Google Scholar 

  18. Joseph MA, Harlow SD, Wei JT et al (2003) Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157:906

    Article  Google Scholar 

  19. Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JM et al (2003) Risk factors for lower urinary tract symptoms in a population based sample of African-American men. Am J Epidemiol 157:906–914

    Article  Google Scholar 

  20. Hammarsten J, Högstedt B (2001) Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39:151–158

    Article  CAS  Google Scholar 

  21. Giovannucci E, Rimm EB, Chute CG et al (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140:989

    Article  CAS  Google Scholar 

  22. Haidinger G, Temml C, Schatzl G et al (2000) Risk factors for lower urinary tract symptoms in elderly men. For the prostate study group of the Austrian society of urology. Eur Urol 37:413–420

    Article  CAS  Google Scholar 

  23. Buchheit M, Gindre C (2006) Cardiac parasympathetic regulation: respective associations with cardiorespiratory fitness and training load. Am J Physiol Heart Circ Physiol 291:451–458

    Article  Google Scholar 

  24. Silva V, Grande AJ, Peccin MS (2019) Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev 4(4):CD12044

    Google Scholar 

Download references

Funding

There was no funding to declare.

Author information

Authors and Affiliations

Authors

Contributions

LCMA: protocol/project development, data collection, data management, data analysis, manuscript writing, manuscript editing. CSB: data collection, data management, data analysis, manuscript writing. HEL: protocol/project development, manuscript editing. JMBN: protocol/project development, manuscript editing. AAF: protocol/project development, data analysis, manuscript writing, manuscript editing.

Corresponding author

Correspondence to André Avarese Figueiredo.

Ethics declarations

Conflict of interest

The authors states that there is no conflict of interest to report.

Ethics approval

Número do CAAE: 42684915.1.0000.5133 Issuing authority: Plataforma Brasil. Número do Parecer do CEP: 1.043.224 Issuing authority: Comitê de Ética em Pesquisa do Hospital Universitário da Universidade Federal de Juiz de Fora.

Consent to participate

All patients assigned an informed consent to participate in the present clinical trial.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agostini, L.C.M., Brum, C.S., Lopes, H.E. et al. Evaluation of pedometer use in men with lower urinary tract symptoms: a randomized clinical trial. Int Urol Nephrol 53, 2231–2236 (2021). https://doi.org/10.1007/s11255-021-02970-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-021-02970-z

Keywords

Navigation